Targeting the FGF-Klotho endocrine axis plays a critical role in the pathophysiology of aging-related diseases, such as diabetes, cancer, arteriosclerosis, and chronic kidney disease (16), some of which are associated with obesity (e.g., arteriosclerosis, diabetes, osteoporosis) (17, 18). This evidence concerns the gene KL and Obesity.